Shook Hardy Bacon Shook Hardy Bacon Menu


Success fosters insight; insight informs success. Our representative matters look beyond the immediate solution to the next challenge facing your business and industry.

Of course, past outcomes afford no guarantee of future results. Every case is different and must be judged on its own merits.

Filter By:

Behrens Discusses Disclosure of Third-Party Litigation Funding

Shook, Hardy & Bacon Public Policy Co-Chair Mark Behrens and U.S. Chamber Institute for Legal Reform President Lisa Rickard have authored articles in Financier Worldwide and Law360 that call for “the disclosure of third-party litigation funding at the outset of a lawsuit.”

Insight | Pharmaceutical and Medical Device

Keenan Shares Tips on Preparing Drug and Device Reps for Trial

Shook, Hardy & Bacon Partner Matthew Keenan authored a Sept. 29 Law360 article covering challenges associated with drug and device representative trial witnesses, and tips for defense counsel to best prepare for trial examinations.


Quixotic Fusion Wins Counterclaim Damages in Landlord/Tenant Trial

Shook, Hardy & Bacon attorneys obtained a jury verdict for Quixotic Fusion after the company's former landlord sued for breach of contract.


Deutsch and Spencer Address Bellwether-Trial Trends in Multidistrict Litigation

Shook, Hardy & Bacon Partner Nicholas Deutsch and Associate Jennifer Spencer have published a Westlaw Journal Toxic Torts article that discusses how multidistrict litigation (MDL) courts select bellwether trials to help manage the large number of cases pending in MDLs.

Insight | Pharmaceutical and Medical Device

Stubbs and Copeland Discuss Litigation Implications of Biomaterials Access Assurance Act for Medical Device Manufacturers

Shook, Hardy & Bacon Partner Jennise Stubbs and Associate Kelsey Copeland have authored a September 14, 2016, article in Bloomberg BNA’s Medical Devices Law & Industry Report™, exploring how the Biomaterials Access Assurance Act (BAAA) can help both biomaterial suppliers and medical device manufacturers facing litigation brought by multiple plaintiffs.